RANJAN BISTA to Molecular Targeted Therapy
This is a "connection" page, showing publications RANJAN BISTA has written about Molecular Targeted Therapy.
Connection Strength
0.031
-
Clinical resistance associated with a novel MAP2K1 mutation in a patient with Langerhans cell histiocytosis. Pediatr Blood Cancer. 2018 09; 65(9):e27237.
Score: 0.031
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.